
What Is Tianeptine? Warning Issued Over 'Gas Station Heroin'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The U.S. Food and Drug Administration (FDA) has stepped up warnings about tianeptine, an unapproved antidepressant increasingly sold in gas stations and convenience stores under names like "Zaza," "Tianna," and "Neptune's Fix."
The substance, dubbed "gas station heroin" for its opioid-like effects, is illegal and not approved for medical use in the U.S., although it is legally marketed in some countries as an antidepressant.
Why It Matters
Tianeptine can be found in some gas stations and convenience stores, often with packaging that mimics legal supplements. Its misuse has drawn increasing attention, particularly due to the way it mimics the effects of opioids, and can cause serious and even fatal side effects.
According to the FDA, poison control center cases involving tianeptine exposure causing severe side effects have increased nationwide, from 11 in total between 2000 and 2013 to 151 in 2020 alone.
What To Know
Despite being illegal, the drug is sometimes illicitly added to foods and beverages or sold as a dietary supplement in the U.S. by some firms.
An FDA spokesperson told Newsweek: "The FDA has taken steps to protect people from tianeptine products, including warning consumers that tianeptine is an unsafe food additive."
The administration has also issued warning letters to companies distributing and selling unlawful tianeptine products, and issued import alerts to stop tianeptine shipments at the border.
A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine.
A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine.
Uncredited/FDA Office of Regulatory Affairs, Health Fraud Branch via AP
What Is Tianeptine?
Tianeptine acts on the brain's opioid receptors, which can produce feelings of euphoria at high doses, and the products feature claims—without evidence or FDA approval—that they can help users treat medical conditions, including addiction, pain and depression.
"Tianeptine has been used in tens of millions of patients over decades in Europe, Asia and South America and is well documented to be an antidepressant with efficacy roughly similar to first-line antidepressants," Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek.
Tianeptine is taken recreationally by some, and has been used to self-treat a variety of ailments, as well as being used chronically. However, abruptly stopping it use can induce withdrawal symptoms similar to those associated with opioids, such as craving, sweating, diarrhea, and others.
"Despite this, it has a remarkably safe track record in Europe and the abuse rate when used clinically is extremely low," Javitch said.
He also said that used clinically, "there is no immediate perceptible effect on mood," and patients do not experience euphoria.
Javitch specializes in experimental therapeutics in psychiatry and is a professor of molecular pharmacology and therapeutics at Columbia.
"Doses six times the clinical dose were shown not to produce euphoria, and thus tianeptine works over time through changing brain chemistry and circuitry and synaptic structure," he said. However, he added that taking high doses in "an uncontrolled way is problematic."
Javitch stressed that he did not believe products containing tianeptine should be sold in "an uncontrolled way with little oversight over dosing or combination with other medication."
According to the FDA, reported adverse effects can include agitation, coma, confusion, death, drowsiness, hypertension, nausea, difficulty breathing, sweating, tachycardia (irregular heartbeat) and vomiting.
In 2024, there was a cluster of illnesses in New Jersey associated with the product "Neptune's Fix," which was found to contain tianeptine and synthetic cannabinoid receptor triggers. Adverse effects included tachycardia, seizure and even death.
FDA Crackdown
The FDA has been taking frequent steps in recent years to warn the public about the dangers of the drug, as well as trying to crack down on companies that include the ingredient in their products.
The agency recommends that health care professionals "encourage patients to avoid all products containing tianeptine, including those claiming to treat an ailment or disorder."
Instead, the FDA said they should speak to their patients about evidence-based treatment options for opioid use disorder, or cases of depression, anxiety, or pain.
States are also taking action independently, and currently a dozen have banned or restricted the sale of tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee.
What People Are Saying
Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek: "I don't think it should be available at gas stations in an uncontrolled way with little oversight over dosing or combination with other medication. I fear that people will use much higher doses than are clinically indicated, and can escalate dosing and mix with other compounds."
He added: "We just have to remember that tianeptine may have major potential as a treatment for depression and anxiety in the right patients, and we are trying to develop a precision psychiatry approach to predicting just which patients will respond to the mediation when used appropriately."
Commissioner of Food and Drugs Dr. Martin Makary said in a note last month on the subject: "I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth.
"While the FDA is closely following the distribution and sale of these products, it is critical that you appreciate the magnitude of the underlying danger of these products, and disseminate information about it."
He added: "Historically, there has been a delayed recognition of fast-growing trends, such as opioid abuse and vaping addiction in youth. Let's be proactive in understanding and addressing the use of tianeptine products, which are available even to our nation's youth."
What Happens Next
The FDA said it will continue working with local and federal partners to crack down on illegal tianeptine products. It also urged consumers to report any adverse reactions involving tianeptine to the agency's MedWatch program.
This article contains reporting by The Associated Press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
an hour ago
- Business Wire
Dr. Adam S. Arthur Joins inTRAvent Medical as the Chief Clinical Strategy Officer to Lead Clinical Strategy and Guide Platform Development
BLUE BELL, Pa.--(BUSINESS WIRE)--inTRAvent Medical, a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve neurosurgical procedures, proudly announces the appointment of Dr. Adam S. Arthur, MD, MPH, as Chief Clinical Strategy Officer (CCSO). In this role, Dr. Arthur will lead the company's clinical strategy for the upcoming launch of inTRAvent's platform for external ventricular drain (EVD) placement, SOLOPASS ®, while guiding the development of additional minimally invasive applications. "Bringing advanced neuronavigation featuring real-time imaging to the bedside has the potential to change the standard of care for EVD placement." Dr. Arthur brings a wealth of experience to inTRAvent Medical, with a distinguished career in both open cerebrovascular and endovascular neurosurgery. As the James T. Robertson Endowed Professor and Chair of Neurosurgery at the University of Tennessee Health Science Center, and a practicing neurosurgeon at Semmes Murphey Clinic, he has been at the forefront of neurovascular treatment advancements. His leadership in clinical trials, including the pivotal WEB-IT, STEM, and MIND studies, underscores his commitment to advancing innovation to improve patient outcomes. inTRAvent's FDA cleared SOLOPASS ® delivers real-time ultrasound imaging during EVD placement procedures, integrating frameless fixation with a rigid guidance system designed to support precise localization and navigation in critical-care environments. 'Bringing advanced neuronavigation featuring real-time imaging to the bedside has the potential to change the standard of care for EVD placement,' Arthur said. 'Importantly, this platform also creates a pathway for minimally invasive approaches to treating intracranial hemorrhage – without the need to move critically ill patients from the ICU.' The SOLOPASS system, designed from inception for the critical-care setting, combines 2D and 3D ultrasound imaging, AI, and trajectory guidance to provide real-time intra-procedural localization and navigation – avoiding the limitations of traditional systems, which rely on preoperative images that can become unreliable and no longer reflect actual anatomy due to brain shift or evolving pathology. 'Dr. Arthur's exceptional expertise and forward-thinking approach to neurosurgery make him an invaluable addition to our team,' said inTRAvent Medical's CEO, Adam Barner. 'His insights will help guide the continued clinical development of our SOLOPASS ® platform to address significant unmet clinical needs.' About inTRAvent Medical Partners inTRAvent Medical Partners is a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve the safety and efficacy of neurosurgical procedures. Its first product, SOLOPASS®, enables simple, portable neuro-navigation using 2D and 3D ultrasound imaging, artificial intelligence, and trajectory guidance for intra-procedural localization and navigation. For more information, please visit or find us on LinkedIn.


CNBC
an hour ago
- CNBC
Kraft Heinz to remove artificial dyes from U.S. products by end of 2027
Kraft Heinz said Tuesday that it will remove FD&C artificial dyes from its products by the end of 2027, and will not launch any new products in the U.S. containing those ingredients. The company said in a release that about 10% of its U.S. items use FD&C colors, the synthetic additives that make many foods more visually appealing. Kraft Heinz brands that sell products with these dyes include Crystal Light, Kool-Aid, MiO, Jell-O and Jet-Puffed, according to a Kraft Heinz spokesperson. The company removed artificial colors, preservatives and flavors from its Kraft macaroni and cheese in 2016 and its Heinz ketchup has never used artificial dyes, according to Pedro Navio, North America president at Kraft Heinz. It is unclear how removing the dyes will affect the company's business, as consumers could perceive the products as healthier but also may be less drawn to duller colors. The decision follows pressure from the U.S. Food and Drug Administration and Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., for the food industry to pull back on artificial dyes as part of a larger so-called Make America Healthy Again platform. The FDA in April announced a plan to phase out the use of petroleum-based synthetic dyes by the end of next year and replace them with natural alternatives. Besides the previously banned Red No. 3, other dyes that will be eliminated include red dye 40, yellow dye 5, yellow dye 6, blue dye 1, blue dye 2 and green dye 2, FDA Commissioner Marty Makary said at the time. Kennedy said at the time that the FDA and the food industry have "an understanding," not a formal agreement, to remove artificial dyes. The Health and Human Services secretary discussed removing artificial food dyes during a meeting in March with top food executives from companies including Kraft Heinz, PepsiCo North America, General Mills, WK Kellogg, Tyson Foods, J.M. Smucker and the Consumer Brands Association, the industry's top trade group. A spokesperson for Kraft Heinz said on Tuesday that the company looks forward to partnering with the administration "to provide quality, affordable, and wholesome food for all." Momentum against food dyes had been building for years. In January, before President Donald Trump and Kennedy took office, the FDA announced a ban on the use of Red No. 3 dye in food and ingested drugs. The dye gives many candies and cereals their bright red color, but is also known to cause cancer in laboratory animals. The FDA allowed Red No. 3 to be used by food manufacturers for years, though the state of California had already banned the dye in 2023. Kraft Heinz said in the release Tuesday that it has made more than 1,000 recipe changes over the past five years to improve product nutrition. "The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of FD&C colors across the remainder of our portfolio," Navio said. "Above all, we are focused on providing nutritious, affordable and great-tasting food for Americans and this is a privilege we don't take lightly."
Yahoo
an hour ago
- Yahoo
Kraft Heinz to remove artificial colors from Jell-O and Kool Aid, among other brands, by 2027
Kraft Heinz (KHC) is getting rid of synthetic dyes across the remaining 10% of its US portfolio that contains them. That means changes are coming for beverage and dessert items like Crystal Light, Kool-Aid, Jell-O, and the marshmallow brand Jet Puffed. Kraft Heinz will remove the artificial colors and replace them with natural colors. If that is not possible, it plans to reinvent the items with new colors. Effective immediately on Tuesday, the company will not launch any new products that contain the food additives. "The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of Food, Drug & Cosmetic (FD&C) colors across the remainder of our portfolio," North America president Pedro Navio said in the release. The company removed artificial flavors, colors, and preservatives from Kraft Mac & Cheese in 2016. This announcement comes amid growing scrutiny of food additives. During the final days of former former President Joe Biden's term, the Food and Drug Administration (FDA) announced the ban of Red Dye No. 3 by 2027. In April, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said he wants "real and transformative" change by "getting the worst ingredients out' of food, according to a letter viewed by Yahoo Finance that summarized the HHS secretary's remarks to the Consumer Brands Association. By the time he leaves office, RFK Jr. wants to remove artificial coloring from the entire food supply. Per the list of ingredients, Kool-Aid Unsweetened Grape Powdered Drink Mix available on Walmart's website contains Red 40 and Blue 1. Another offering, Kool-Aid Unsweetened Cherry Powdered Soft Drink Mix, contains Blue 1. Strawberry Jell-O has "artificial flavor" listed under the title and includes Red 40 in the ingredients. This comes as Kraft Heinz, General Mills (GIS), and WK Kellogg (KLG) are facing multiple headwinds, including healthier eating trends, GLP-1s, and the impact of macro uncertainty in general, causing consumers to be extra intentional about discretionary snack purchases. Kraft Heinz's overall portfolio — ranging from Jell-O to Lunchables — saw its volume mix drop 5.6 percentage points in the quarter. Kellanova (K), which is behind brands like Cheez-Its and Pringles, saw its volume decline in North America. The company is in the process of being acquired by Mars. Brooke DiPalma is a senior reporter for Yahoo Finance. Follow her on X at @BrookeDiPalma or email her at bdipalma@ Click here for all of the latest retail stock news and events to better inform your investing strategy Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data